Next Article in Journal
Temporal Limitations of the Standard Leaky Integrate and Fire Model
Previous Article in Journal
Midday Napping and Successful Aging in Older People Living in the Mediterranean Region: The Epidemiological Mediterranean Islands Study (MEDIS)
Open AccessEditorial

Current Therapeutic Strategies for Glioblastoma

by Julien Rossignol 1,2,3,*, Bhairavi Srinageshwar 1,2,3 and Gary L. Dunbar 1,2,4,5
1
Field Neurosciences Institute laboratory for Restorative Neurology at Central Michigan University, Mt. Pleasant, MI 48859, USA
2
Program in Neuroscience, Central Michigan University, Mt. Pleasant, MI 48859, USA
3
College of Medicine, Central Michigan University, Mt. Pleasant, MI 48859, USA
4
Department of Psychology, Central Michigan University, Mt. Pleasant, MI 48859, USA
5
Field Neurosciences Institute, St. Mary’s of Michigan, Saginaw, MI 48604, USA
*
Author to whom correspondence should be addressed.
Brain Sci. 2020, 10(1), 15; https://doi.org/10.3390/brainsci10010015
Received: 23 December 2019 / Accepted: 24 December 2019 / Published: 26 December 2019
Glioblastomas (GB) are grade 4 brain tumors, one of the most aggressive forms of brain cancer found in humans. Although current treatments for GB are largely ineffective, new alternate approaches, beyond standard chemo- or radiation therapies have shown promising results in both pre-clinical and clinical settings. Some of these approaches include stem cell therapy, new pharmaceuticals and nutraceuticals, and the use of tumor specific peptides or GB-targeted antibodies and immune-based therapies. A common limitation in the efficacy of these treatments is the inability of these therapeutic agents to readily cross the blood–brain barrier (BBB) to reach the tumor site. Therefore, many strategies are being developed to achieve targeted delivery of drugs across the BBB so that they can kill the cancer cells, while sparing healthy tissue. One of the most promising new approaches involves the use of nanoparticles that can carry therapeutic drugs and genes across the BBB and home in on the GB tumor site. View Full-Text
Keywords: glioblastoma; drugs and genes; blood brain barrier glioblastoma; drugs and genes; blood brain barrier
MDPI and ACS Style

Rossignol, J.; Srinageshwar, B.; Dunbar, G.L. Current Therapeutic Strategies for Glioblastoma. Brain Sci. 2020, 10, 15.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop